A study from Queen Mary University of London shows the South Asian community in the UK could benefit from personalised genetic testing for medication usage. Despite South Asians making up 10% of the British population, they are under-represented in genomics studies. Many South Asians have higher rates of conditions like diabetes and heart disease. DNA testing to personalise medication regimes can reduce side effects and increase effectiveness. Trust plays a key role in genomics engagement. Concerns around privacy, data ownership, potential data breaches and increased medication costs must be addressed.
100 MILLION Americans in UnitedHealth PII Breach
UnitedHealth confirmed that February’s ransomware attack impacted 100 million people, the largest healthcare data breach in the US. Health insurance, health, billing, and personal information
